Cargando…
Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development
Dengue has become the most important arboviral infection worldwide with more than 30 million cases of dengue fever estimated to occur each year. The need for a dengue vaccine is great and several live attenuated dengue candidate vaccines are proceeding through clinical evaluation. The need to induce...
Autores principales: | Durbin, Anna P., Whitehead, Stephen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205382/ https://www.ncbi.nlm.nih.gov/pubmed/22069516 http://dx.doi.org/10.3390/v3101800 |
Ejemplares similares
-
Primary Vaccination with Low Dose Live Dengue 1 Virus Generates a Proinflammatory, Multifunctional T Cell Response in Humans
por: Lindow, Janet C., et al.
Publicado: (2012) -
‘Mix and Match’ vaccination: Is dengue next?
por: Odio, Camila D., et al.
Publicado: (2022) -
Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
por: Dotiwala, Farokh, et al.
Publicado: (2023) -
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
por: Jafari, Ameneh, et al.
Publicado: (2022) -
Current progress in dengue vaccines
por: Wan, Shu-Wen, et al.
Publicado: (2013)